Navigation Links
Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
Date:3/31/2009

the anthrax Protective Antigen (PA) of the lethal toxin complex produced by the bacterium. Preclinical studies suggest that Valortim(R) has the potential to provide significant protection against anthrax infection when administered prophylactically post-exposure (i.e., prior to the emergence of symptoms of anthrax infection) and also may increase survival when administered therapeutically (i.e., once symptoms become evident).

As previously presented, Valortim(R) has been administered intravenously and intramuscularly to healthy human volunteers in a completed Phase 1 study, was well tolerated at doses as high as 20 mg/kg (IV), and was not immunogenic. Pharmacokinetic analysis suggested that doses as low as 1 mg/kg resulted in circulating levels of antibody after a month, with a similar potency for neutralizing anthrax toxin in vitro as was seen with serum obtained from subjects who had been vaccinated with anthrax vaccine.

Anti-toxins such as Valortim(R) are a key element in combating and treating anthrax infection, in addition to vaccines and antibiotics. The Department of Health and Human Services has issued a requirement for up to 200,000 anthrax anti-toxin treatments to be included in the Strategic National Stockpile and PharmAthene believes that Valortim(R) is well positioned to address this need.

About Anthrax

According to the Centers for Disease Control and Prevention, anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in hoofed mammals and can also infect humans. Symptoms of disease vary depending on how the disease is contracted, but usually occur within seven days after exposure. The serious forms of human anthrax are inhalation anthrax, cutaneous anthrax, and intestinal anthrax. Initial symptoms of inhalation anthrax infection may resemble a common cold. After several days, the symptoms may progress to severe breath
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Columbia , May 5, 2015  InMed ... clinical stage biopharmaceutical company that specializes in developing ... former GW Pharmaceuticals financier, investor, and Non-Executive Director, ... InMed as Strategic Advisor with primary responsibility for ... role, Mr. Mountford will leverage his previous success ...
(Date:5/4/2015)... an effort to raise awareness and the need for ... the Health Equity Hero Awards to celebrate the efforts ... than 83 million people in the United ... barriers are most significant for those who experience health ... literacy or geographic isolation.   "Connecting people with ...
(Date:5/4/2015)... Texas, May 4, 2015 Luminex Corporation (NASDAQ: ... ended March 31, 2015. Financial and operating highlights include the ... million, a 2 percent increase over the first quarter of ... a 17 percent increase over the first quarter of 2014. ... the first quarter of 2015.  , GAAP net income ...
Breaking Medicine Technology:InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 2DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 3DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 4Luminex Corporation Reports First Quarter 2015 Results 2Luminex Corporation Reports First Quarter 2015 Results 3Luminex Corporation Reports First Quarter 2015 Results 4Luminex Corporation Reports First Quarter 2015 Results 5Luminex Corporation Reports First Quarter 2015 Results 6Luminex Corporation Reports First Quarter 2015 Results 7Luminex Corporation Reports First Quarter 2015 Results 8Luminex Corporation Reports First Quarter 2015 Results 9Luminex Corporation Reports First Quarter 2015 Results 10Luminex Corporation Reports First Quarter 2015 Results 11
... Resource Expands its Deal... -- OXFORD, England, August 19, 2010 ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
... MINNEAPOLIS, Aug. 19 Protectus Medical Devices, Inc. ... marketer of innovative medical devices, today named physician/surgeon ... Dr. Hartley has vast experience in research and ... quality control, medical writing and regulatory compliance.  He ...
Cached Medicine Technology:As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage 2As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage 3As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage 4As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage 5As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage 6As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage 7Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices 2Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices 3
(Date:5/4/2015)... 04, 2015 Global Vision, the ... technologies, today announced that it will showcase Proofware ... City Center, in Nashville Tennessee, May 04 and ... first true all-in-one we-based packaging inspection suite, giving ... security of their brand copy and artwork. Proofware ...
(Date:5/4/2015)... 2015 HHT is a rare but ... While it can have seemingly mild symptoms like frequent ... Hereditary Hemorrhagic Telangiectasia (HHT) is a hereditary disorder ... normal capillary connections between an artery and a vein. ... nosebleeds, but may also be present in the lungs, ...
(Date:5/4/2015)... 04, 2015 In a continuing effort ... substance absue, Per Wickstrom, the founder of Choices Recovery ... and the “Salute to the Oscars” celebration held ... the top floor of the luxurious Beverly Hilton Hotel. ... producer of sustainable product placement in TV and film, ...
(Date:5/4/2015)... HERSHEY, Pa. (PRWEB) May 04, 2015 ... M.D. ’87, the 2015 Alumnus of the Year, recognizing ... of excellence and philanthropy he sets for MHS students. ... spark that can happen when children are provided a ... find and hone their passions,” said Pete Gurt ’85, ...
(Date:5/4/2015)... 04, 2015 Each year, the Susan G. ... funds and awareness for breast cancer. This year, Dr. Mark ... featured as the entertainment sponsor for the 25th annual Susan ... 9 at the Lenox Square Mall. , The Komen organization ... to raise $1.2 million. Perimeter Plastic Surgery has not only ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2
... the efficacy of anticancer vaccines There are ... which are designed to boost the patient,s anticancer immune ... viruses used to deliver the tumor protein to the ... immune system, inducing neutralizing and suppressive responses. But now, ...
... lung cancer (NSCLC), five-year disease-free survival is currently the benchmark ... the follow-up standards: (1) When can cure be declared with ... continued? In order to define a strategy for long-term ... the August edition of the Journal of Thoracic Oncology ...
... studies challenge the controversial hypothesis that venous congestionchronic ... multiple sclerosis (MS). This theory has resulted in ... treatment for MS unproven by clinical trials. The ... negative medical evidence on the subject, are available ...
... today announced that the United States (U.S.) Food and ... botulinum toxin type A for the treatment of adults ... study conducted in Rochester, Minnesota, the prevalence of focal ... at 295 per million people in the U.S. ...
... found that cancer patients from poorer communities have a ... affluent backgrounds even though cancer stage at time of ... in CANCER , a peer-reviewed journal of the ... needed to understand and reduce disparities in the survival ...
... five hospitals in the United States have developed an advanced ... helps radiologists and other physicians extract useful data from a ... manner, according to an article in the August issue of ... ( www.jacr.org ). "Even in its simplest implementation, ...
Cached Medicine News:Health News:JCI online early table of contents: August 2, 2010 2Health News:JCI online early table of contents: August 2, 2010 3Health News:JCI online early table of contents: August 2, 2010 4Health News:JCI online early table of contents: August 2, 2010 5Health News:JCI online early table of contents: August 2, 2010 6Health News:Research defines timeframes, factors to deem early stage lung cancer cured 2Health News:New studies question vascular multiple sclerosis hypothesis and treatment 2Health News:New studies question vascular multiple sclerosis hypothesis and treatment 3Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 2Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 3Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 4Health News:Socioeconomic status predicts survival of Canadian cancer patients 2Health News:Researchers develop advanced search tool to help physician's sort and retrieve vital EMR data 2
... all Gilson disposable pipette tips, ... sterilized version. Each Sterilized TowerPack ... device-quality plastic to help protect ... guaranteed by the red sticker, ...
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
... Aerosol barrier tips eliminate false ... Scientifically designed and tested, Promega Barrier ... working with amplified nucleic acids (PCR(a)), ... samples, forensic and serological specimens. , ...
Inquire...
Medicine Products: